Delete
Are you sure you want to delete the Feed “https://www.fiercepharma.com/rss/xml”? All of the following related items will be deleted:
Summary
- Feeds: 1
- Entries: 110
Objects
- Feed: https://www.fiercepharma.com/rss/xml
- Entry: <a href="https://www.fiercepharma.com/pharma/eha-jj-sharpens-myeloma-edge-talvey-darzalex-faspro-combo-proves-its-worth-earlier-disease" hreflang="en">EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage </a>
- Entry: <a href="https://www.fiercepharma.com/regulatory/cms-proposes-permanent-framework-medicare-drug-price-negotiations" hreflang="en">CMS proposes permanent framework for Medicare drug price negotiations</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/oral-glp-1-tracker-launch-trajectories-lilly-foundayo-novo-wegovy-pill" hreflang="en">The Oral GLP-1 Tracker: Novo’s Wegovy keeps gaining ground in obesity market</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fda-hearing-amgens-tavneos-will-include-findings-independent-review" hreflang="en">FDA hearing on Amgen's Tavneos will include findings from an independent review</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/latest-twist-zepzelca-saga-jazz-and-pharmamar-lung-cancer-drug-fails-phase-3-test" hreflang="en">In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026" hreflang="en">Regulatory tracker: Novo's oral GLP-1 picks up UK approval</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/eli-lilly-biogen-eisai-and-genentech-sponsor-new-lets-talk-alzheimers-podcast" hreflang="en">Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/astellas-ceo-5-year-plan-takeda-psoriasis-win-ra-china-bridge-program" hreflang="en">Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/not-simply-saving-cost-inside-astellas-ceo-5-year-strategy-counter-xtandi-patent-cliff" hreflang="en">‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff</a>
- Entry: <a href="https://www.fiercepharma.com/biotech/genentech-executes-another-round-layoffs-3-vps-axed" hreflang="en">Genentech executes another round of layoffs, with 3 VPs axed</a>
- Entry: <a href="https://www.fiercepharma.com/ai-and-machine-learning/all-hhs-agencies-saw-ai-use-case-increases-fy-2025-bipartisan-policy-center" hreflang="en">AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/novo-reports-cybersecurity-breach-tells-clinical-trial-patients-remain-vigilant" hreflang="en">Novo reports data breach, tells clinical trial patients to 'remain vigilant'</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/joint-initiative-5-eu-countries-calls-unified-approach-pharma-framework-amid-us-drug-pricing" hreflang="en">Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/jj-shows-results-trial-could-lead-rare-disease-expansion-imaavy" hreflang="en">J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/madrigal-takes-giant-inflatable-liver-us-tour-disease-awareness-push" hreflang="en">Madrigal takes giant inflatable liver on US tour in disease awareness push</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/olixir-ny-teams-crohns-colitis-foundation-its-spill-your-guts-campaign" hreflang="en">Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/if-thats-not-acceleration-i-dont-know-what-novo-nordisk-ceo-doustdar-talks-leadership-new" hreflang="en">‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO </a>
- Entry: <a href="https://www.fiercepharma.com/biotech/takedas-tyk2-inhibitor-beats-bristol-myers-sotyktu-psoriasis-showdown" hreflang="en">Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/eli-lilly-yells-action-authentic-patient-portrayals-tribeca-festival" hreflang="en">Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/amid-growing-industry-backlash-germanys-healthcare-reform-plan-pfizer-ceo-bourla-re" hreflang="en">Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters </a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/how-lab-data-powers-precision-commercialization-drive-therapy-adoption" hreflang="en">How lab data powers precision commercialization to drive therapy adoption</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/legacy-approach-real-world-data-costing-you" hreflang="en">The legacy approach to real-world data is costing you</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/why-mrd-becoming-central-oncology-drug-development" hreflang="en">Why MRD is becoming central to oncology drug development</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/asco-2026-showed-precision-oncologys-next-challenge-translation" hreflang="en">ASCO 2026 showed that precision oncology’s next challenge is translation</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/european-commission-approves-cinnagens-zandoriahr-teriparatide-biosimilar-osteoporosis" hreflang="en">European Commission Approves CinnaGen’s Zandoriah® (teriparatide biosimilar) for Osteoporosis in Adults</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/lilly-oncology-chief-went-extremely-nervous-blown-away-new-jaypirca-cll-data" hreflang="en">Lilly oncology chief went from ‘extremely nervous’ to ‘blown away’ by new Jaypirca CLL data</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/eisai-snares-government-manufacturing-grant-it-brings-leqembi-packaging-uk-65m" hreflang="en">Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/mercks-welireg-keytruda-pairing-sticks-landing-adjuvant-kidney-cancer-treatment-new-fda-nod" hreflang="en">Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/iqvia-taps-ai-put-overlooked-prescribers-marketers-maps" hreflang="en">IQVIA taps AI to put overlooked prescribers on marketers’ maps</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/once-fda-pathway-speed-its-approval-sanfoi-gains-late-expansion-tzield" hreflang="en">Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/beyond-china-and-japan-how-biopharma-expanding-rare-disease-access-across-asia-pacific" hreflang="en">Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/germany-backs-plan-install-variable-discount-pricing-drugs" hreflang="en">Germany backs off plan to install variable discount pricing on drugs: report</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/recipharm-pump-multi-millions-us-manufacturing-operations" hreflang="en">Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/stealth-biotherapeutics-removes-cloak-become-mighty" hreflang="en">Stealth BioTherapeutics removes cloak to become Mighty </a>
- Entry: <a href="https://www.fiercepharma.com/marketing/phrma-talks-power-medicines-first-new-campaign" hreflang="en">PhRMA talks up the power of ‘Medicines First’ in new campaign </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/moderna-hires-banque-lead-commercial-creates-larger-role-hoge" hreflang="en">Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fda-uk-drug-regulator-deepen-transatlantic-ties-new-liaison-program" hreflang="en">FDA, UK drug regulator deepen transatlantic ties with new liaison program</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/deepintent-gives-helix-ai-twist-help-marketers-query-data" hreflang="en">DeepIntent gives Helix an AI twist to help marketers query data</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/ma-volume-and-value-indicate-biopharma-ecosystem-back-full-health-pwc" hreflang="en">'Biopharma ecosystem is back to full health,' fueled by M&A: PwC</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/after-fda-sign-colorados-canadian-drug-import-plan-faces-tough-road-ahead" hreflang="en">After FDA sign-off, Colorado's drug import plan faces tough road ahead</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/novos-security-breach-claimed-hacking-groups-attempted-squeeze-multi-million-ransom-bids" hreflang="en">Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/novo-nordisk-opens-czech-plant-unveils-29m-upgrade-china-facility" hreflang="en">Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/gsk-runs-first-dtc-ad-would-be-asthma-blockbuster-exdensur" hreflang="en">GSK runs first DTC ad for would-be asthma blockbuster Exdensur</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/four-more-years-and-partnership-gsk-allow-spero-get-utebzi-across-fda-finish-line" hreflang="en">4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/despite-decent-data-verastem-rethinks-options-approved-oncology-combo-pancreatic-cancer" hreflang="en">Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer</a>
- Entry: <a href="https://www.fiercepharma.com/biotech/nortiva-purrs-action-long-acting-lynx-platform-salvaged-langer-startup" hreflang="en">Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/cellares-ori-reign-supreme-automated-cell-therapy-manufacturing-advances-report" hreflang="en">Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/pfizer-searches-new-cfo-denton-prepares-hang-gloves-wave-goodbye-pharma" hreflang="en">Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/novos-success-oral-wegovy-has-been-fueled-familiarity-spherix" hreflang="en">Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix</a>
- Entry: <a href="https://www.fiercepharma.com/providers/eli-lillys-ultimatum-hospitals-send-340b-claims-data-june-1-or-lose-discounts" hreflang="en">Eli Lilly cuts 340B discounts for hospitals resisting its claims data submission policy</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/ftc-advises-aurobindo-divest-4-drugs-complete-250m-acquisition-lannett" hreflang="en">FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/big-pharmas-big-brand-deep-dive-pharmas-marketing-culture-eli-lilly" hreflang="en">Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/eli-lilly-novo-nordisk-top-ai-citation-share-new-report-questions-dtc-spend-culture" hreflang="en">Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/why-deviation-investigation-still-takes-two-weeks-age-ai" hreflang="en">Why a deviation investigation still takes two weeks in the age of AI</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/us-investigate-germanys-proposed-drug-spending-reforms" hreflang="en">US to investigate Germany's proposed drug spending reforms</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/alnylam-scolded-over-promotional-activity-after-pfizer-complaint" hreflang="en">Alnylam scolded over promotional activity after Pfizer complaint</a>
- Entry: <a href="https://www.fiercepharma.com/biotech/5-month-sprint-behind-pfizer-10b-deal-and-innovent-global-pharma-ambition" hreflang="en">A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/carsgens-gastric-cancer-car-t-nabs-world-first-approval-china-checking-landmark-solid-tumor" hreflang="en">CARsgen makes history as China approves world's first CAR-T therapy for solid tumors</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/big-obesity-bets-and-chinas-rise-fuel-potential-2t-2032-drug-sales-evaluate" hreflang="en">Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/whistleblower-suit-accuses-genentech-novartis-running-decades-long-kickback-scheme-allergy" hreflang="en">Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/novartis-relax-your-tight-end-cancer-campaign-wins-cannes-lions-pharma-grand-prix" hreflang="en">Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/real-world-data-powers-next-gen-biopharma" hreflang="en">Real-world data powers next-gen biopharma</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/incyte-drops-lawsuit-cms-relents-classification-opzelura" hreflang="en">Incyte drops lawsuit as CMS relents on classification of Opzelura</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/revance-taps-dancer-julianne-hough-choreograph-social-media-push-botox-rival" hreflang="en">Revance taps dancer Julianne Hough to choreograph social media push for Botox rival</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/advancell-enters-long-term-lease-us-radiopharmaceutical-production" hreflang="en">AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/nature-retracts-provocative-pd-1-study-tied-lung-cancer-survival-treatment-timing" hreflang="en">Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/amid-safety-concerns-adc-therapeutics-plots-17-staff-cuts-push-resources-behind-lead-adc" hreflang="en">Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/stada-under-new-capvest-ownership-picks-horde-european-consumer-health-brands-orifarm" hreflang="en">Stada, under new CapVest ownership, picks up horde of European consumer brands</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/lilly-exec-says-company-will-focus-telehealth-sales-obesity-pill-europe-report" hreflang="en">Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/pfizer-scores-its-first-expansion-7-years-breast-cancer-blockbuster-ibrance" hreflang="en">Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance</a>
- Entry: <a href="https://www.fiercepharma.com/biotech/mapp-gilead-antivirals-be-deployed-drc-ebola-trial-who-chief" hreflang="en">Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/gilead-trodelvy-nabs-broad-fda-approval-front-line-tnbc-fueling-trop2-adc-market-war" hreflang="en">Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/astrazeneca-spells-out-community-cancer-screening-strategy-ymca" hreflang="en">AstraZeneca spells out a community cancer screening strategy with the YMCA</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/novartis-teams-becoming-rentable-its-new-sma-campaign" hreflang="en">Novartis teams up with Becoming rentABLE for its new SMA campaign </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/ionis-scores-landmark-fda-label-expansion-tryngolza" hreflang="en">Ionis scores transformational FDA label expansion for Tryngolza</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/jubilant-hollisterstier-gets-fda-warning-letter-quality-control-problems" hreflang="en">Jubilant HollisterStier gets FDA warning letter for quality control problems</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/merck-kgaa-throws-down-113b-bio-techne-biggest-deal-2015-sigma-aldrich-buy" hreflang="en">Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/fda-shines-harsh-light-pinnacle-after-finding-fault-photodynamic-therapy-videos" hreflang="en">FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/bayer-scores-major-win-scotus-overturns-roundup-verdict" hreflang="en">Bayer scores landmark victory as Supreme Court overturns Roundup verdict</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fosun-pharma-plots-global-push-beyond-oncology-fueled-multi-asset-alzheimers-strategy" hreflang="en">Fosun Pharma plots global push beyond oncology, fueled by multi-asset Alzheimer’s strategy</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/beone-boosts-support-blood-cancer-united-5m-commitment" hreflang="en">BeOne boosts support for Blood Cancer United with $5M commitment</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/historic-solid-tumor-car-t-nod-inside-pfizer-innovent-10b-pact-more-china-deals" hreflang="en">Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/biogen-launches-ready-more-hd-spinraza-campaign-focus-how-we-see-sma" hreflang="en">Biogen launches ‘Ready for More’ HD Spinraza campaign with a focus on how we see SMA</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/eli-lilly-taps-ai-being-personal-memories-life-during-its-european-radio-show-road-trip" hreflang="en">Eli Lilly taps AI to bring personal memories to life during its European radio show road trip</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/fda-slaps-dr-reddys-hyderabad-biologics-plant-seven-observations-new-form-483" hreflang="en">FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/sanofi-subject-antitrust-probe-ec-kicks-formal-proceedings" hreflang="en">Sanofi under antitrust probe as European Commission kicks off formal proceedings</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/pharmas-cannes-do-attitude-sees-industry-return-triumph" hreflang="en">Pharma’s Cannes-do attitude sees industry return to triumph </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/chmp-reverses-marketing-recommendation-amgens-tavneos-fda-hearing-looms" hreflang="en">Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/look-out-amgen-here-comes-viridian-fda-nod-ted-med-lumvoa" hreflang="en">Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/zymeworks-acquires-struggling-theravance-929m" hreflang="en">Zymeworks acquires struggling Theravance for $929M</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/fda-rejects-sobi-gout-drug-over-manufacturing-issues-sparing-amgen-blockbuster" hreflang="en">FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/beone-brukinsa-hits-goal-mantle-cell-lymphoma-confirmatory-trial" hreflang="en">BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/klick-bags-oxford-pharmagenesis-3rd-takeover-18-months" hreflang="en">Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/fda-selects-lilly-regeneron-fujifilm-and-4-others-precheck-pilot-program" hreflang="en">FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/unicycive-turned-away-fda-again-over-third-party-manufacturers-shortfalls" hreflang="en">Unicycive turned away by FDA again over manufacturer’s plant shortfalls</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/after-monotherapy-failure-abbvie-and-genmab-tout-epkinly-combo-win-dlbcl" hreflang="en">After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/rising-stars-how-novo-nordisks-tara-sparks-went-super-bowl-fan-super-bowl-marketer" hreflang="en">Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/medical-journal-retracts-tavneos-pivotal-study-article-complicating-amgens-defense-effort" hreflang="en">Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/cmi-media-group-bridges-gaps-pharma-marketing-tech-newly-launched-ad-astra-platform" hreflang="en">CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/astrazeneca-will-pay-34m-settle-free-nurses-kickback-lawsuit" hreflang="en">AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fda-approves-orca-bio-cell-therapy-tregzi-blood-cancer-transplants" hreflang="en">Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/plus-therapeutics-rebrands-cerenome-it-deepens-ai-strategy" hreflang="en">Plus Therapeutics rebrands as Cerenome as it deepens AI strategy </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/kimball-lays-out-103m-bolster-life-sci-cdmo-footprint-across-europe-india" hreflang="en">Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/haleon-teams-microsoft-5-year-corporate-ai-deal-upgrade-consumer-health-operations" hreflang="en">Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/bridgebio-attracts-1b-equity-financing-launches-attruby-potential-new-products" hreflang="en">BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/sanofi-unit-ireland-chided-fda-over-manufacturing-flubs-linked-altuviiio" hreflang="en">Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026-h2" hreflang="en">Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/lonza-expands-partnership-us-drugmaker-and-boosts-its-capacity-produce-adcs" hreflang="en">Lonza expands partnership with US drugmaker, boosts capacity for ADCs</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/tenpoint-brings-everyday-blurry-vision-hassles-life-yuvezzi-consumer-campaign" hreflang="en">Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad </a>
- Entry: <a href="https://www.fiercepharma.com/marketing/roche-tops-oncology-reputation-rankings-astrazeneca-climbs-back-2nd-place" hreflang="en">Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place</a>